First elected: 12th December 2019
Speeches made during Parliamentary debates are recorded in Hansard. For ease of browsing we have grouped debates into individual, departmental and legislative categories.
These initiatives were driven by Sarah Owen, and are more likely to reflect personal policy preferences.
MPs who are act as Ministers or Shadow Ministers are generally restricted from performing Commons initiatives other than Urgent Questions.
Sarah Owen has not been granted any Urgent Questions
Sarah Owen has not been granted any Adjournment Debates
A Bill to make provision about offences relating to the misuse of fireworks and penalties for such offences; and for connected purposes.
A Bill to extend entitlement to parental bereavement leave and pay to parents of babies miscarried or stillborn during early pregnancy; and for connected purposes.
A Bill to make provision about the sale of fireworks; and for connected purposes.
Brain Tumours Bill 2023-24
Sponsor - Siobhain McDonagh (Lab)
Teenagers (Safety and Wellbeing) Bill 2022-23
Sponsor - Alex Norris (LAB)
Brain Tumours Bill 2022-23
Sponsor - Siobhain McDonagh (Lab)
Planning and Local Representation Bill 2021-22
Sponsor - Rachel Hopkins (Lab)
Digitally Altered Body Images Bill 2019-21
Sponsor - Luke Evans (Con)
The Government takes fraud seriously. DSIT works closely with the Home Office, who are responsible for fraud policy, as well as Ofcom who have duty to ensure that UK numbers are not misused, to ensure telecoms companies are doing all they can to prevent criminals hijacking their networks to reach victims. From January, new Ofcom rules will require operators to block calls from abroad which present as a UK number.
We continue to work with the telecoms sector to ensure that as threats evolve so too does the response.
The Government takes fraud seriously. DSIT works closely with the Home Office, who are responsible for fraud policy, as well as Ofcom who have duty to ensure that UK numbers are not misused, to ensure telecoms companies are doing all they can to prevent criminals hijacking their networks to reach victims. From January, new Ofcom rules will require operators to block calls from abroad which present as a UK number.
We continue to work with the telecoms sector to ensure that as threats evolve so too does the response.
I regret that Ministers are not yet able to comment on next steps regarding accessibility projects at specific stations including at Leagrave station. However, please be assured that we are committed to improving the accessibility of the railway and recognise the social and economic benefits this brings to communities. Once we can confirm our approach to individual projects, DfT Ministers will of course ensure that MPs and other key stakeholders are updated.
The following table shows how much the National Institute for Health and Care Research spent on research, as well as that spend as a percentage of total research spend, for gynaecological and urogynaecological, each year from 2014/15 to 2023/34, and in total over that period:
Financial year | Spend | Proportion of total research spend |
2014/15 | £3,820,598 | 1.3% |
2015/16 | £4,119,736 | 1.4% |
2016/17 | £4,598,586 | 1.6% |
2017/18 | £5,794,355 | 1.5% |
2018/19 | £4,876,814 | 1.3% |
2019/20 | £5,558,241 | 1.3% |
2020/21 | £5,255,747 | 1.3% |
2021/22 | £5,808,297 | 1.2% |
2022/23 | £5,472,805 | 1.0% |
2023/24 | £6,381,906 | 1.3% |
Total 2014 to 2024 | £51,687,086 | 1.3% |
Additionally, the following table shows how much the National Institute for Health and Care Research spent on research, as well as that spend as a percentage of total research spend, for asthma, each year from 2014/15 to 2023/34, and in total over that period:
Financial year | Spend | Proportion of total research spend |
2014/15 | £2,881,919 | 1.0% |
2015/16 | £3,148,352 | 1.1% |
2016/17 | £2,222,035 | 0.8% |
2017/18 | £4,451,842 | 1.2% |
2018/19 | £4,999,804 | 1.3% |
2019/20 | £8,823,017 | 2.1% |
2020/21 | £8,950,535 | 2.2% |
2021/22 | £7,378,125 | 1.5% |
2022/23 | £6,947,881 | 1.3% |
2023/24 | £8,733,915 | 1.7% |
Total 2014 to 2024 | £58,537,425 | 1.5% |
Finally, the following table shows how much the National Institute for Health and Care Research spent on research, as well as that spend as a percentage of total research spend, for diabetes, each year from 2014/15 to 2023/34, and in total over that period:
Financial year | Spend | Proportion of total research spend |
2014/15 | £8,886,001 | 3.1% |
2015/16 | £8,570,471 | 2.9% |
2016/17 | £8,899,325 | 3.0% |
2017/18 | £12,240,087 | 3.3% |
2018/19 | £13,180,008 | 3.4% |
2019/20 | £17,097,212 | 4.1% |
2020/21 | £16,899,589 | 4.1% |
2021/22 | £21,713,745 | 4.3% |
2022/23 | £20,346,333 | 3.8% |
2023/24 | £25,271,594 | 5.1% |
Total 2014 to 2024 | £153,104,366 | 3.8% |
The information requested is not held centrally. A range of procedures are used to investigate and treat gynaecological conditions. For example, ultrasound can be used in the diagnosis of fibroids, hysteroscopy can be used to investigate symptoms such as unexplained vaginal bleeding, and laparoscopy can be used to diagnose and treat endometriosis.
The Government recognises that some procedures, such as hysteroscopy, can result in pain, and the level of pain experienced will vary between individual women. It is important that healthcare professionals provide women with information prior to their procedure so that women can make an informed decisions about the procedure and pain relief options, including the option of local or general anaesthetic.
Following referral from the Department, the National Institute for Health and Care Excellence (NICE) is currently planning the development of a guideline on the assessment and management of polycystic ovary syndrome. The NICE is exploring the possibility of collaboration with a reputable, guidance-producing partner to enhance the speed and efficiency of this work. The NICE’s website will be updated at the earliest opportunity, when expected timings are confirmed.
The Department has invested £25 million over 2023/24 and 2024/25 to support the establishment of at least one pilot women’s health hub in every integrated care system. The 2024/25 NHS priorities and operational planning guidance asks integrated care boards (ICBs) to establish and develop at least one women’s health hub in every ICB by December 2024, working in partnership with local authorities.
NHS England has asked the ICBs to report regularly on their progress implementing the funding. As of September 2024, 36 of the 42 ICBs had had reported to NHS England that their women’s health hub was open. Those ICBs are:
The Birmingham, RAND, and Cambridge Evaluation, published in September 2024, identified 17 women’s health hubs in England which were established between 2001 and 2022. The report is available at the following link:
https://www.journalslibrary.nihr.ac.uk/hsdr/JYFT5036/#/abstract
The research notes the difficulty in locating models for women’s health hubs, meaning the research may not have captured all open women’s health hubs, in particular hubs that have opened more recently as locally-led initiatives.
Information on the proportion of general practices commissioned to fit long-acting reversible contraception for the purposes of gynaecological care, as well as the fitting fee and cost of fitting in primary care, is not collected centrally.
We remain committed to the UK Rare Diseases Framework, which highlights helping patients get a final diagnosis faster, and improved access to specialist care, treatment, and drugs as priorities to improve the lives of people with living with rare diseases.
NHS England commissions a service for adults and children with complex neurofibromatosis type 1 (NF1). This is provided by Manchester University NHS Foundation Trust and Guy's and St Thomas' NHS Foundation Trust. The overall aim of the service is to provide the highest quality of care to people with complex NF1 through accurate diagnosis, including genetic testing, coordinated care from a specialist multidisciplinary team, monitoring of complications of the disease, and referral to other specialties as required. The two national centres and a multi-disciplinary team of senior doctors and nurses co-ordinate diagnosis and long-term care of patients with complex NF1. A referral is needed to access this service, and both centres also accept non-complex NF1 referrals. The clinicians in the complex NF1 team contribute to the evidence base on this condition, including development of international guidelines. Genetic testing for NF1 is available through the NHS Genomic Medicine Service.
The National Institute for Health and Care Excellence (NICE) has no plans to develop a guideline on NF1. With the exception of health technology evaluations, where the NICE's responsibilities are clearly defined, the NICE will not routinely produce guidelines that relate to single rare diseases. Instead, they seek to identify commonalities between conditions to provide products that can be applied across multiple rare disease groups.
NICE guidelines are developed by experts based on a thorough assessment of the available evidence, and through extensive engagement with interested parties. They describe best practice, and healthcare professionals are expected to take them fully into account in the care and treatment of their patients, although they are not mandatory and do not override a clinician’s responsibility to make decisions appropriate to individual patients.
The statement from my Rt hon. Friend, the Chancellor of the Exchequer on 29 July 2024 sets out the position across the Government, and includes departments making savings to pay towards the outcomes of the Pay Review Bodies. As the process for agreeing savings is not yet complete, at this point we cannot provide the breakdown requested.
However, the Government is committed to ensuring the National Health Service receives the funding it needs to pay for this deal. There will be no reduction in the availability or quality of frontline health and care services as a consequence of funding this pay award.
Any Barnett consequential would be provided to the devolved administrations in the usual way. Any additional funding that flows to the Department as a result would be at supplementary estimates in 2024/25.
The Sudan conflict has created the worst humanitarian crisis in the world with 24.8 million people in need of assistance. The UK is extremely concerned about the increasing cases of cholera in Sudan with death rates from the outbreak surging up to three times the global average. The UK is responding though our humanitarian programmes in Sudan. The UK has spent £113.5 million this year in response to the conflict in Sudan and the resulting regional refugee crisis. As part of this funding, we support the Sudan Humanitarian Fund which provides flexible, muti-sector support to NGOs, including medical relief for the cholera outbreak.
As soon as the Foreign Secretary came into office, he commissioned new advice on Israel's compliance with International Humanitarian Law, in the context of the war. This is an important and complex process, requiring detailed analysis of evidence, and close co-operation with other Government Departments, and is being undertaken urgently. The Foreign Secretary's decision, and the Government's decision on the related issue of arms exports, will be made public when the process is complete.
I discussed my concerns regarding the violence in Bangladesh following protests with the Bangladesh High Commissioner to London on 19 and 23 July. The British High Commissioner has engaged with key ministers in the Bangladesh government to reinforce messages on de-escalation and the need for constructive dialogue to reduce tensions. The rights to protest, to peacefully assemble and to express different political views are rights the UK holds dear and must be protected. We will continue to raise the importance of respect for human rights and the rule of law with the Bangladesh government.
The Foreign Secretary and I have publicly called for an immediate end to the violence and unrest in Bangladesh, and for all sides to find a peaceful way forward. I discussed the situation with the Bangladesh High Commissioner to London on 19 and 23 July and stressed the need for democratic freedoms and the rule of law to be protected. The British High Commissioner to Bangladesh has engaged with Bangladesh government ministers reinforcing messages on de-escalation and the need for constructive dialogue to reduce tensions. We are monitoring the situation closely and will continue to engage with counterparts.
The selling of timeshares is outside of Financial Conduct Authority (FCA) regulation and therefore outside of the remit of the Financial Ombudsman Service (FOS), which can only consider complaints about FCA regulated activities. Where consumers have purchased a timeshare using a product regulated by the FCA, such as consumer credit, they may have recourse to the FOS if that product was mis-sold.
When complaints are made to the FOS, these should be dealt with in a timely manner. The Financial Conduct Authority (FCA) Handbook, which sets out the rules on how the FOS should handle complaints, states that ‘the ombudsman will attempt to resolve complaints at the earliest possible stage’. In its Plans and Budget 2024-25, the FOS has set itself the target of resolving 90 per cent of cases within 6 months and the government will continue to hold the FOS to account on this through its regular engagement with the FOS.
A full economic Impact Assessment (IA) was produced relating to the potential impacts of changes to the eligibility of student visa holders to bring dependants. The IA is available at:
2023 changes to the student route and consequential changes to work routes: impact assessment (publishing.service.gov.uk)
Home Office also publish monthly statistics on visas issued (including those on study visas and their dependants). These statistics do not consider the extent to which the lower volumes relative to last year are attributable to the specific policy changes in question. The monthly statistics are available at:
Monthly monitoring of entry clearance visa applications - GOV.UK (www.gov.uk)
HM Prison & Probation Service is committed to delivering sustained improvement in living conditions and performance across the prison estate, to promote a safe and secure environment that facilitates genuine rehabilitation. Since the publication of HM Inspectorate of Prison's latest report on the prison, HMP Bedford has prioritised the improvement of living conditions, by introducing a programme of cleaning, maintenance, pest control and decency checks.
The new Governor, appointed in February, is continuing to monitor performance at the prison to ensure sustained improvement.
The Government recognises the importance that faith and belief can have in someone’s rehabilitation, and the role it can play in reducing re-offending. That is why we have been clear that we should include this in planning and work across prisons and probation, and with communities, to strengthen support available.
Faith and belief services, together with pastoral care in prison in England and Wales, are delivered by multi-faith Chaplaincy teams in all prisons and young offender institutions in the secure state, in accordance with the requirements of the Prison Act 1952, the Prison Rules 1999, the Young Offender Rules 2000 and Prison Service Instruction 05/2016 Faith and Pastoral Care of Prisoners.
The delivery of these services is monitored through Quality, Assurance and Development visits to prisons, inspections by HM Inspectorate of Prisons, and the annual reports of prison Independent Monitoring Boards.